Conservation of personal protective equipment for head and neck cancer surgery during COVID-19 pandemic.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32342543.
- Also identified by DOI 10.1002/hed.26215 and PMC identifier 7267333.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
COVID-19 pandemic has led to a global shortage of personal protective equipment (PPE). This study aims to stratify face shield needs when performing head and neck cancer surgery. Fifteen patients underwent surgery between March 1, 2020 and April 9, 2020. Operative diagnosis and procedure; droplet count and distribution on face shields were documented. Forty-five surgical procedures were performed for neck nodal metastatic carcinoma of unknown origin (n = 3); carcinoma of tonsil (n = 2), tongue (n = 2), nasopharynx (n = 3), maxilla (n = 1), and laryngopharynx (n = 4). Droplet contamination was 57.8%, 59.5%, 8.0%, and 0% for operating, first and second assistant surgeons, and scrub nurse respectively. Droplet count was highest and most widespread during osteotomies. No droplet splash was noted for transoral robotic surgery. Face shield is not a mandatory adjunctive PPE for all head and neck surgical procedures and health care providers. Judicious use helps to conserve resources during such difficult times.
Medical subject headings
- Coronavirus Infections
- Infectious Disease Transmission, Patient-to-Professional
- Monitoring, Intraoperative
- Occupational Health
- Pandemics
- Personal Protective Equipment
- Pneumonia, Viral